MyoKardia, Inc. Common Stock
MYOK
MYOK was delisted on the 16th of November, 2020.
63 hedge funds and large institutions have $233M invested in MyoKardia, Inc. Common Stock in 2016 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 31 increasing their positions, 7 reducing their positions, and 1 closing their positions.
1,800% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 1
343% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 7
89% more capital invested
Capital invested by funds: $123M → $233M (+$110M)
40% more funds holding
Funds holding: 45 → 63 (+18)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$27M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$15.3M |
| 3 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$6.4M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.87M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$3.76M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$3.22M |
| 2 |
CC
Casdin Capital
New York
|
-$344K |
| 3 |
TCIM
TIAA CREF Investment Management
New York
|
-$39.8K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$8K |
| 5 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$4.51K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $65K | +$41.6K | +2,302 | +134% |
|
|
BA
52
BlackRock Advisors
Wilmington,
Delaware
| $64K | +$12.3K | +680 | +21% |
|
|
SO
53
STRS Ohio
Columbus,
Ohio
| $58K | -$1.81K | -100 | -3% |
|
|
TIM
54
Tortoise Investment Management
White Plains,
New York
| $56K | – | – | – |
|
|
TRCT
55
Tower Research Capital (TRC)
New York
| $55K | +$32.9K | +1,822 | +118% |
|
|
SIG
56
Stanford Investment Group
Mountain View,
California
| $52K | – | – | – |
|
57
Legal & General Group
London,
United Kingdom
| $33K | – | – | – |
|
58
Creative Planning
Overland Park,
Kansas
| $33K | +$7.22K | +400 | +25% |
|
59
Citigroup
New York
| $15K | -$3.79K | -210 | -19% |
|
60
BNP Paribas Financial Markets
Paris,
France
| $13K | +$7.13K | +395 | +99% |
|
61
BlackRock
New York
| $9K | +$2.78K | +154 | +37% |
|
|
IA
62
IFP Advisors
Tampa,
Florida
| $8K | +$5.42K | +300 | +150% |
|
63
Bank of America
Charlotte,
North Carolina
| $7K | +$4.6K | +255 | +120% |
|
|
TCIM
64
TIAA CREF Investment Management
New York
| $735 | -$39.8K | -2,204 | -5% |
|
|
65
UBS Group
Zurich,
Switzerland
| – | -$8K | -651 | Closed |
|
MYOK Hedge Fund Activity: Q3 2016 in Review
63 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in MyoKardia, Inc. Common Stock (MYOK) for Q3 2016, worth a combined $233M — up 89% from $123M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new MYOK positions and 1 closed out — a net gain of 18 holders — while 31 added to existing stakes and 7 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $27M. The largest seller was JP Morgan Chase, cutting an estimated $3.22M.
- 63 institutional investors held MyoKardia, Inc. Common Stock (MYOK) as of Q3 2016, up from 45 in Q2 2016.
- Funds reported $233M of MyoKardia, Inc. Common Stock stock for Q3 2016, up 89% quarter-over-quarter.
- 19 funds opened new MyoKardia, Inc. Common Stock positions in Q3 2016 and 1 closed out, a net change of +18 holders.
- The largest MyoKardia, Inc. Common Stock buyer in Q3 2016 was Wellington Management Group, an estimated $27M added.
- The largest MyoKardia, Inc. Common Stock seller in Q3 2016 was JP Morgan Chase, an estimated $3.22M sold.
Based on aggregated 13F filings for Q3 2016.